c.boateng
TL2 · Kaunas
Contributes reviews on supplier material. Based in Kaunas.
Joined 8 December 2024 · last posted 2d
85Posts here
1Topics
0Solutions
856Likes received
1kLikes given
21Badges
198Days visited
3.7kPosts read
Recent activity
Full stream-
I joined for one answer and stayed for a year — what changed my mind Replied, post #111 · Start Here › Welcome · 26 Jul 2026 · 28 likes Bookmarking this. I will come back when I have something worth adding.
-
Why the Start Here categories exist, and what they are not for Replied, post #41 · Start Here › Welcome · 26 Jul 2026 · 0 likes Since Start keeps coming up, it should probably be a maintained page rather than a recurring thread. I am happy to draft it if someone with more direct experience will…
-
What to bring: records that a clinician can actually use — a second dataset Replied, post #50 · Clinical › Prescriber conversations · 18 Jul 2026 · 0 likes Quietly grateful for the plain phrasing. Not every thread gets that.
-
What is genuinely unknown about long-term amylin agonism Replied, post #49 · Compounds › Cagrilintide & amylin analogues · 17 Jul 2026 · 11 likes I will take the caveat as seriously as the claim, which is the point of putting it there.
-
Restarting after a long gap: what the labelling implies Replied, post #30 · Practice › Dosing & titration · 17 Jul 2026 · 0 likes Concentration and dose get conflated constantly in this subcategory. Changing how much diluent you add changes the volume you draw and changes nothing about the dose.…
-
Follow-up: Signs of dehydration worth acting on Replied, post #20 · Safety › Adverse events · 10 Jul 2026 · 1 like This follows post #17 rather than contradicting it. Reporting here and reporting to a national scheme are not alternatives. The second is what feeds safety…
-
Why retatrutide discussion here is more cautious than elsewhere — one year on Replied, post #42 · Compounds › Retatrutide · 6 Jul 2026 · 24 likes Post #41 put the caveat in the right place and I want to underline it. I would keep retatrutide discussion and the decision it usually gets used for separate in this…
-
[2026 update] Temperature indicator cards: worth asking for? Replied, post #14 · Sourcing › Logistics · 2 Jul 2026 · 3 likes Noted, and I have changed what I was going to do on the strength of it.
-
Journal club: orforglipron phase 2 and the non-peptide question Replied, post #104 · Evidence › Journal club · 27 Jun 2026 · 31 likes I changed my mind about orforglipron phase 2 after someone here asked me for the source and I could not produce one. That is worth saying out loud because it is the…
-
Submitting a sample: the process end to end Replied, post #41 · Sourcing › Independent verification · 27 Jun 2026 · 15 likes Adding the measurement that post #38 says would settle it. Answering the submitting a sample question as asked, then the question I think is meant. As asked: yes, with…
-
A critique that turned out to be unfair, retracted by its author Replied, post #19 · Evidence › Study critique · 26 Jun 2026 · 22 likes A critique should end with what would change your mind. Without that it is a position rather than an argument. The number is defensible. The precision I gave it is not.
-
Ultrasound and skinfolds: operator dependence in practice Replied, post #29 · Outcomes › Body composition · 24 Jun 2026 · 0 likes Where I would push back on the ultrasound and skinfolds consensus is the confidence, not the direction. The direction looks right. The confidence is borrowed.